Zoetis to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody Therapies for Companion Animals

/in ,

Purchase price of US$6.72 per share, or approximately US$85 million in aggregate Acquisition to strengthen Zoetis’ pipeline in companion animal therapeutics for chronic pain, a global area estimated at US$400 million annually1 PARSIPPANY, N.J. & TULLAMORE, Ireland–(BUSINESS WIRE)–Apr. 13, 2017– Link here Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced an agreement in which Zoetis, through a wholly owned subsidiary (“Zoetis Bidco”), will purchase […]

Read more

FDA Approves Increased Compassionate Use Patient Cases and Sites for ReCell®

/in

Valencia, CA, Perth, Australia and London, United Kingdom, 7 April 2017 – link here The U.S. Food and Drug Administration has approved a further increase in the number of patients who can be treated in the United States with the ReCell® regenerative medical device under a compassionate use protocol, Avita Medical Ltd. (ASX: AVH), (OTCQX: […]

Read more

AmpliPhi Biosciences Announces Presentations of Clinical and Preclinical Data from Studies with its Bacteriophage Technology at Two Scientific Conferences

/in

CATEGORY: Featured Tuesday, April 4, 2017 6:50 am EDT – link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB “AmpliPhi and our partners have produced promising clinical and nonclinical data demonstrating AmpliPhi’s phage cocktails are safe and active against a broad footprint of isolates, including those that are multidrug-resistant” SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation […]

Read more

Come meet Adherium at RDD Europe 2017

/in

Garth Sutherland, Adherium CEO & Founder, selected as a Speaker and author at the upcoming meeting, RDD Europe 2017 to be held April 25-28, 2017, at Palais des Congres d’Antibes, Nice (Antibes), France. Link here Garth will present on Thursday, April 27, during Session 3: Can Connected Devices Improve Respiratory Outcomes? 9.30 a.m. ‘Track and Remind’: Can […]

Read more

Adherium chosen as Finalist in NZ Hi-Tech Awards

/in

A record number of people gathered across Auckland, Christchurch and Wellington to hear the finalists announced for the 2017 NZ Hi-Tech Awards. – link here Entries this year came from as far afield as Kaitaia and Invercargill which have resulted in a record number of entries being received, up 30% on last year. Wayne Norrie, […]

Read more

AmpliPhi Biosciences Reports 2016 Fourth-Quarter and Full-Year Results and Provides Corporate Highlights

/in

Monday, March 27, 2017 4:11 pm EDT – Link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB “The growing incidence of antibiotic-resistant bacterial infections is a major health threat that is recognized by governments and health authorities around the world” SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development […]

Read more

Avita Medical to Present at Needham Healthcare Conference

/in

Valencia, CA, USA, Perth, Australia and London, United Kingdom, 23 March 2017 — Link here Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects, today announced that Adam Kelliher, Avita’s Chief Executive Officer will present at the 16th Annual Needham Healthcare Conference on 4 April 2017. […]

Read more

Avita Announces $975k R & D Tax Incentive

/in

Valencia, CA, USA, Perth, Australia and Cambridge, United Kingdom, 16 March 2017 — Link here Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects, today announced that it has received a Research and Development Tax Incentive cash rebate from the Australian Tax Office of A$974,908 for […]

Read more

Avita Medical Announces Last Patient Visit in U.S. Pivotal Trial

/in

Clinical data collected from final patient, completing trial • Company plans PMA submission upon receipt of shelf-life stability data • PMA decision anticipated during the 2nd calendar quarter of 2018 Valencia, CA, USA, Perth, Australia and Cambridge, United Kingdom, 7 March 2017 — link here Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused […]

Read more

U.S. FDA Approves increased Compassionate Use Patient Cases and Sites for ReCell® in Life-Threatening Injuries

/in ,

U.S. FDA Approves increased Compassionate Use Patient Cases and Sites for ReCell® in Life-Threatening Injuries • Up to 48 patients can now be treated at 15 US burnscenters • Increased use of ReCell® device by US surgeons under the Compassionate Use dispensations • Latest FDA approval separate to approval earlier in the month for Continued […]

Read more